Meiser BM and Reichart B |
New trends in clinical immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527954
|
Hara Y et al. |
Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527955
|
Ohtsuka S et al. |
Hamster-to-rat xenotransplantation of whole pancreas by FK 506 combined with splenectomy. |
1994 |
Transplant. Proc. |
pmid:7513473
|
Hu RH et al. |
Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:11119894
|
Tzakis AG et al. |
Two-year experience with FK 506 in pediatric patients. |
1993 |
Transplant. Proc. |
pmid:7679822
|
Iwata H et al. |
Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin. |
1994 |
Transplant. Proc. |
pmid:7513476
|
Ochiai T et al. |
Effective and safe use of FK 506: combination treatment with rapamycin or RS-61443 in experimental organ transplantation. |
1991 |
Transplant. Proc. |
pmid:1721255
|
Ciancio G et al. |
Current advantage of FK 506 in cadaveric kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623207
|
Pham SM et al. |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience. |
1996 |
Transplant. Proc. |
pmid:8623208
|
Demetris AJ et al. |
Pathologic observations in human allograft recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689891
|
Jain A et al. |
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. |
1998 |
Transplant. Proc. |
pmid:9636567
|
Matevossian E et al. |
Liver transplantation in the rat: single-center experience with technique, long-term survival, and functional and histologic findings. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715990
|
Videla CO |
Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715995
|
Melo MJ et al. |
Impact of conversion from Advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study. |
2015 |
Transplant. Proc. |
pmid:26036484
|
Viganó J et al. |
Incidence of graft rejection in small bowel transplanted pigs after immunosuppression withdrawal. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908291
|
Hossain MA et al. |
Effect of the immunosuppressants FK506 and D-allose on allogenic orthotopic liver transplantation in rats. |
2000 |
Transplant. Proc. |
pmid:11120048
|
Sekido H et al. |
Successful conversion from cyclosporine to tacrolimus for immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11120096
|
Woan MC et al. |
Characterization of the biopsy growth assay in monitoring cardiac transplant patients for rejection. |
1993 |
Transplant. Proc. |
pmid:7680171
|
Kliem V et al. |
Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576041
|
Rilo HR et al. |
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. |
1993 |
Transplant. Proc. |
pmid:7680172
|
Friemann S et al. |
Conversion to tacrolimus in hyperlipidemic patients. |
1999 |
Transplant. Proc. |
pmid:10576042
|
Yilmaz A et al. |
Severe angioedema caused by banana allergy under tacrolimus immunosuppression. |
2005 |
Transplant. Proc. |
pmid:16387091
|
Lai WJ et al. |
Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation? |
2004 |
Transplant. Proc. |
pmid:15518744
|
Francavilla A et al. |
The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo. |
1991 |
Transplant. Proc. |
pmid:1721287
|
Carobbi A et al. |
Synergism of splenectomy and immunosuppressive drugs in prolongation of cardiac xenograft survival. |
1992 |
Transplant. Proc. |
pmid:1373543
|
Blanc P et al. |
Antiproliferative effect of FK 506 and cyclosporine on adult human hepatocytes in culture. |
1991 |
Transplant. Proc. |
pmid:1721288
|
Ueno M et al. |
Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation. |
1992 |
Transplant. Proc. |
pmid:1373546
|
Kyo M et al. |
Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin. |
1996 |
Transplant. Proc. |
pmid:8623457
|
D'Silva M et al. |
Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623467
|
Perrella A et al. |
Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience. |
2010 |
Transplant. Proc. |
pmid:20534267
|
Colak H et al. |
Relationship of Interleukin-10 and Transforming Growth Factor-β Levels With Short-Term Graft Function After Kidney Transplantation. |
2015 |
Transplant. Proc. |
pmid:25964218
|
Peddi VR et al. |
Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636626
|
Chen JS et al. |
Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus. |
2009 |
Transplant. Proc. |
pmid:19545678
|
Cabello M et al. |
Pharmacokinetics of once- versus twice-daily tacrolimus formulations in kidney transplant patients receiving expanded criteria deceased donor organs: a single-center, randomized study. |
2010 |
Transplant. Proc. |
pmid:20970603
|
Mueller AR et al. |
Association between hepatitis and rejection: upregulation of cytokines and extracellular matrix parameters. |
1997 |
Transplant. Proc. |
pmid:9365585
|
Li D et al. |
Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms. |
2006 |
Transplant. Proc. |
pmid:17112846
|
Villamil F et al. |
Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. |
2006 |
Transplant. Proc. |
pmid:17112875
|
Deardon DJ et al. |
Small bowel tonometry: a possible technique for detecting early small bowel allograft dysfunction. |
1993 |
Transplant. Proc. |
pmid:7505502
|
Ohtsuka S et al. |
Mechanism of antibody production in guinea pig to rat discordant xenotransplant: establishment of a simple model by intravenous injection of discordant splenocytes. |
1994 |
Transplant. Proc. |
pmid:7518130
|
Tullius SG et al. |
ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results. |
2003 |
Transplant. Proc. |
pmid:14529854
|
Manu MA et al. |
Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression. |
1999 |
Transplant. Proc. |
pmid:10578313
|
Woodle ES et al. |
FK 506 rescue therapy: early conversion improves efficacy. |
1993 |
Transplant. Proc. |
pmid:7682359
|
Loss M et al. |
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients. |
1995 |
Transplant. Proc. |
pmid:7533365
|
Ushigome H et al. |
Two cases of tacrolimus-induced alopecia following kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10578326
|
Woo J et al. |
Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes. |
1991 |
Transplant. Proc. |
pmid:1721319
|
Petan JA et al. |
Physiochemical properties of generic formulations of tacrolimus in Mexico. |
2008 |
Transplant. Proc. |
pmid:18589125
|
Abecassis MM et al. |
Patient outcomes and economics of once-daily tacrolimus in renal transplant patients: results of a modeling analysis. |
2008 |
Transplant. Proc. |
pmid:18589126
|
Ito Y et al. |
Inhibition of epithelial replacement by nonspecific immunosuppressants accelerates rat orthotopic tracheal allograft rejection. |
2002 |
Transplant. Proc. |
pmid:12176430
|
Shibutani S et al. |
FK 506 abrogates induction of regulatory cells after intratracheal delivery of alloantigen. |
2002 |
Transplant. Proc. |
pmid:12176432
|
Ping X et al. |
Antigen sampling on the Peyer's patches in a murine small bowel transplantation model. |
2010 |
Transplant. Proc. |
pmid:21094860
|
Marin M et al. |
Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. |
2005 |
Transplant. Proc. |
pmid:15919484
|
Shirakata Y et al. |
The minimum graft size for successful orthotopic partial liver transplantation in the canine model. |
1995 |
Transplant. Proc. |
pmid:7533422
|
Felser I et al. |
Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721350
|
Kumano K et al. |
Role of endothelin in FK 506-induced renal hypoperfusion in rats. |
1995 |
Transplant. Proc. |
pmid:7533423
|
Alessiani M et al. |
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721351
|
Tanabe K et al. |
Outcome of kidney transplantation from non-heart-beating donors followed by tacrolimus immunosuppression in japan. |
2002 |
Transplant. Proc. |
pmid:12176493
|
Ramirez CB et al. |
Early steroid withdrawal after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9838406
|
Liu Y et al. |
Delayed Initiation of Tacrolimus Is Safe and Effective in Renal Transplant Recipients With Delayed and Slow Graft Function. |
2018 |
Transplant. Proc. |
pmid:30316359
|
Shapiro R |
Tacrolimus (FK-506) in kidney transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123077
|
Borda B et al. |
Functional and histopathologic changes in renal transplant patients with new-onset diabetes and dyslipidemia. |
2011 |
Transplant. Proc. |
pmid:21620104
|
Reggiani P et al. |
Oral administration of FK 506 in a swine model of liver-small bowel allotransplantation. |
1996 |
Transplant. Proc. |
pmid:8907965
|
Jiang H et al. |
FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro. |
1994 |
Transplant. Proc. |
pmid:7520631
|
Wada Y et al. |
Expression of the transcriptional factor egr-1/BTEB2 in cardiac xenograft vascular remodeling. |
2000 |
Transplant. Proc. |
pmid:10936371
|
Takayama K et al. |
Nonmuscle myosin heavy chain and nuclear factor-kappa B expression in pig-to-primate xenotransplanted hearts. |
2000 |
Transplant. Proc. |
pmid:10936372
|
Moutabarrik A et al. |
In vitro FK 506 kidney tubular cell toxicity. |
1991 |
Transplant. Proc. |
pmid:1721383
|
Moons P et al. |
Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen. |
2002 |
Transplant. Proc. |
pmid:12176538
|
Beaunoyer M et al. |
Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: a single center experience. |
2002 |
Transplant. Proc. |
pmid:12176540
|
Boots JM et al. |
Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176541
|
Navia MA |
Rational design of new immunosuppressive drugs. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083489
|
McAlister VC et al. |
Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083495
|
Lee S et al. |
Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea. |
2010 |
Transplant. Proc. |
pmid:20430174
|
Basadonna GP et al. |
Pancreas after kidney transplantation: HLA mismatch does not preclude success. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123470
|
Kato Y et al. |
Epidermal growth factor enhances the intestinal adaptation of small bowel allografts in the postoperative period. |
2000 |
Transplant. Proc. |
pmid:10995935
|
Yamashita T et al. |
Prolongation of pancreaticoduodenal allograft survival in rats by treatment with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721414
|
Sugito K et al. |
A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658683
|
Yamanaka K et al. |
Induction Immunosuppressive Therapy With Everolimus and Low-Dose Tacrolimus Extended-Release Preserves Good Renal Function at 1Â Year After Kidney Transplantation. |
2016 |
Transplant. Proc. |
pmid:27234735
|
Rigotti P et al. |
Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation. |
2002 |
Transplant. Proc. |
pmid:12176623
|
Akbas SH et al. |
The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients. |
2006 |
Transplant. Proc. |
pmid:16797284
|
Franke GH et al. |
Switching from cyclosporine to tacrolimus leads to improved disease-specific quality of life in patients after kidney transplantation. |
2006 |
Transplant. Proc. |
pmid:16797285
|
Salazar A et al. |
Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267181
|
Ziedina I et al. |
Reactivation of BK Virus in the Early Period After Kidney Transplantation. |
2009 |
Transplant. Proc. |
pmid:19328975
|
Yoshimura R et al. |
Hepatocyte growth factor: a sensitive indicator for CsA-induced nephropathy. |
1998 |
Transplant. Proc. |
pmid:9723373
|
Burrows L et al. |
Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9723378
|
Propper DJ et al. |
Evidence that FK 506 may abrogate suppressor cell activity induced by blood transfusion. |
1991 |
Transplant. Proc. |
pmid:1721446
|
Fabrega AJ et al. |
FK 506 enhances the beneficial effects of donor-specific blood transfusion on allograft survival in rats. |
1991 |
Transplant. Proc. |
pmid:1721447
|
Winkler M et al. |
Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7689277
|
Viebahn R et al. |
Simulation of hypoxic and preservation injury in human hepatocyte cultures: influence of FK 506 and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7689278
|
Wang CH et al. |
Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan. |
2004 |
Transplant. Proc. |
pmid:15561256
|
Heffron TG et al. |
Daclizumab induction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267408
|
Nakai T et al. |
Immunologic changes in heterotopic and orthotopic small bowel transplantation in rats. |
1999 |
Transplant. Proc. |
pmid:10500761
|
Krüger B et al. |
Different effects of cyclosporine or tacrolimus on hepatocyte acute phase proteins. |
1998 |
Transplant. Proc. |
pmid:9636399
|
Rong G et al. |
Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. |
2010 |
Transplant. Proc. |
pmid:21094796
|
Zhang J et al. |
Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients. |
2010 |
Transplant. Proc. |
pmid:21094797
|
Barak S et al. |
Alveolar bone height in patients after liver transplantation. |
2000 |
Transplant. Proc. |
pmid:10856558
|
Gotsman I et al. |
Effect of peripheral immune tolerance on liver-associated lymphocytes expressing NK1.1. |
2000 |
Transplant. Proc. |
pmid:10856569
|
Wong YT et al. |
Audit of diabetes in a renal transplant population. |
2005 |
Transplant. Proc. |
pmid:16298573
|
Shapiro R |
The development of tacrolimus in renal transplantation. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750356
|
Blume C et al. |
Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750357
|
Morris-Stiff G et al. |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report. |
1998 |
Transplant. Proc. |
pmid:9636506
|
Busque S et al. |
Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636507
|